Case Report on Long COVID-19

Published on:November 2021
Indian Journal of Pharmacy Practice, 2021; 14(4):320-324
Case Report | doi:10.5530/ijopp.14.4.67

Case Report on Long COVID-19

Authors and affiliation (s):

Ganesh Kamath1, Muthukumar Mani2, Nagarathna Poojary2,*

1Department of General medicine, Dr. N. R. Acharya Memorial Hospital, Udupi, Karnataka, INDIA.

2Department of Pharmacy Practice, Faculty of Pharmaceutical Science, PES University, Bangalore (formerly as PES College of Pharmacy), Karnataka, INDIA


COVID-19 has dominated the whole world and resulted in increased morbidity and mortality. Here we present a case report of 54-years-old man with repeated admissions to the hospital after severe COVID-19 pneumonia which on progression lead to sepsis with bronchitis. There was Dexamethasone induced hyperglycaemia and was administered with antibiotics, corticosteroids, anti-asthmatics and COPD preparations. He was recurrently admitted to hospital for 4 times and was on oxygen support. These recurrent admissions lead to decreased quality of life and increased healthcare cost. Polypharmacy was on peak and underlying condition was not subsided. Prompt diagnosis and early interventions regarding COVID-19 complications must include a good scientific approach.

Key words: Pneumonia, Bronchitis, COVID-19, Sepsis, Hyperglycemia, Polypharmacy.


The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.


IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs